JasonRobertStubbsMD

Nephrology • Kansas City, KS

Associate Professor, Internal Medicine, University Kansas School of Medicine

Join to view full profile

Dr. Stubbs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stubbs' full profile

Already have an account?

Office
3901 Rainbow Blvd
# MS3002
Kansas City, KS 66160
Phone+1 913-588-6074

Fax+1 913-588-3867

Education & Training

University of Kansas School of MedicineFellowship, Nephrology, 2005 - 2007
University of Kansas School of MedicineResidency, Internal Medicine, 2002 - 2005
University of Kansas School of MedicineClass of 2002

Certifications & Licensure

MO State Medical License 2021 - 2026
KS State Medical License 2005 - 2025

Awards, Honors, & Recognition

Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease Start of enrollment: 2008 May 01
Completed
Not Applicable
Impact of Vitamin D Therapies on Chronic Kidney Disease Start of enrollment: 2010 Oct 01
Completed
Not Applicable
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease Start of enrollment: 2011 Oct 01
Completed
Not Applicable

Publications & Presentations

PubMed

Osteopontin deletion attenuates cyst growth but exacerbates fibrosis in mice with cystic kidney disease.
Kyle P Jansson, Jordan Kuluva, Shiqin Zhang, Taylor Swanson, Yan Zhang
Physiological Reports. 2024-09-01
2 citations
Correction of Vascular Calcification and Hyperphosphatemia in CKD Rats Treated with ASARM Peptide.
Peter S Rowe, Ellen M McCarthy, Alan L Yu, Jason R Stubbs
Kidney360. 2022-10-27
3 citations
Critical Role of Osteopontin in Maintaining Urinary Phosphate Solubility in CKD.
Jason R Stubbs, Shiqin Zhang, Kyle P Jansson, Timothy A Fields, Joseph Boulanger
Kidney360. 2022-09-29

Lectures

Kidney, Bone, and Vasculature: Is the Gut a New Piece of the Puzzle?
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Other

Overview of the causes and treatment of hyperphosphatemia
Stubbs JR, Yu AS
http://www.uptodate.com/contents/overview-of-the-causes-and-treatment-of-hyperphosphatemia
UpToDate, Wolters Kluwer Health - 2013-03-04

Press Mentions

TMAO Implicated as a Cardiovascular Risk Factor in CKDAugust 5th, 2015

Grant Support

Exploring The Interrelationships Of Mineral Metabolism Pathways In Kidney DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
Clinical Trial: Extrarenal 1-Alpha-Hydroxylase In End-Stage Renal DiseaseNational Center For Research Resources2009